Showing results (61-70 of 527) with videos related to

Sort By:
Pageof 53
Biomarkers in Medicine|October 16, 2010
Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studiesBrit Mollenhauer, Omar M A El-Agnaf, Katrin Marcus, et al.
Neuropsychology|February 17, 2022
Dynamic interplay of cognitive functioning and depressive symptoms in patients with Parkinson's diseaseUlrich Schroeders, Johannes Zimmermann, Tamara Wicke, et al.
Movement Disorders Clinical Practice|May 12, 2021
Incidence and Progression of Rapid Eye Movement Behavior Disorder in Early Parkinson's DiseaseLarissa Zimansky, Maria-Lucia Muntean, Andreas Leha, et al.
Cells|February 9, 2020
Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-SynucleinKatalin Barkovits, Niels Kruse, Andreas Linden, et al.
NPJ Biofilms and Microbiomes|July 24, 2025
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson's diseaseRémy Villette, Polina V Novikova, Cédric C Laczny, et al.
Brain Research|November 3, 2005
Normal hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with Huntington's diseaseAndreas Meier, Brit Mollenhauer, Stefan Cohrs, et al.
Methodsx|March 10, 2017
Metabolic profiling of body fluids and multivariate data analysisJean-Pierre Trezzi, Christian Jäger, Sara Galozzi, et al.
The Lancet. Neurology|November 15, 2025
Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settingsAngeliki Zarkali, Michael Bartl, Nick C Fox, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 1, 2010
LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ßChin-Hsien Lin, Pei-I Tsai, Ruey-Meei Wu, et al.
Pageof 53